Unbiased	B:C1711255
estimates	I:C1711255
of	O
cerebrospinal	O
fluid	I:C0007806
β-	O
amyloid	I:C0169424
1	I:C0169424
-	I:C0169424
42	I:C0169424
cutoffs	O
in	O
a	O
large	O
memory	O
clinic	I:C0442592
population	O
.	O

Unbiased	O
estimates	I:C1711255
of	O
cerebrospinal	B:C0007806
fluid	I:C0007806
β-	O
amyloid	I:C0169424
1	I:C0169424
-	I:C0169424
42	I:C0169424
cutoffs	O
in	O
a	O
large	O
memory	O
clinic	I:C0442592
population	O
.	O

Unbiased	O
estimates	I:C1711255
of	O
cerebrospinal	O
fluid	I:C0007806
β-	B:C0169424
amyloid	I:C0169424
1	I:C0169424
-	I:C0169424
42	I:C0169424
cutoffs	O
in	O
a	O
large	O
memory	O
clinic	I:C0442592
population	O
.	O

Unbiased	O
estimates	I:C1711255
of	O
cerebrospinal	O
fluid	I:C0007806
β-	O
amyloid	I:C0169424
1	I:C0169424
-	I:C0169424
42	I:C0169424
cutoffs	O
in	O
a	O
large	O
memory	B:C0442592
clinic	I:C0442592
population	O
.	O

Unbiased	O
estimates	I:C1711255
of	O
cerebrospinal	O
fluid	I:C0007806
β-	O
amyloid	I:C0169424
1	I:C0169424
-	I:C0169424
42	I:C0169424
cutoffs	O
in	O
a	O
large	O
memory	O
clinic	I:C0442592
population	B:C1257890
.	O

We	O
sought	O
to	O
define	O
a	O
cutoff	O
for	O
β-	B:C0169424
amyloid	I:C0169424
1	I:C0169424
-	I:C0169424
42	I:C0169424
in	O
cerebrospinal	O
fluid	I:C0007806
(	O
cerebrospinal	O
fluid	I:C0007806
)	O
,	O
a	O
key	O
marker	O
for	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
(	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
)	O
,	O
with	O
data	O
-	O
driven	O
Gaussian	O
mixture	I:C0026348
modeling	I:C0026348
in	O
a	O
memory	O
clinic	I:C0442592
population	O
.	O

We	O
sought	O
to	O
define	O
a	O
cutoff	O
for	O
β-	O
amyloid	I:C0169424
1	I:C0169424
-	I:C0169424
42	I:C0169424
in	O
cerebrospinal	B:C0007806
fluid	I:C0007806
(	O
cerebrospinal	O
fluid	I:C0007806
)	O
,	O
a	O
key	O
marker	O
for	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
(	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
)	O
,	O
with	O
data	O
-	O
driven	O
Gaussian	O
mixture	I:C0026348
modeling	I:C0026348
in	O
a	O
memory	O
clinic	I:C0442592
population	O
.	O

We	O
sought	O
to	O
define	O
a	O
cutoff	O
for	O
β-	O
amyloid	I:C0169424
1	I:C0169424
-	I:C0169424
42	I:C0169424
in	O
cerebrospinal	O
fluid	I:C0007806
(	O
cerebrospinal	B:C0007806
fluid	I:C0007806
)	O
,	O
a	O
key	O
marker	O
for	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
(	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
)	O
,	O
with	O
data	O
-	O
driven	O
Gaussian	O
mixture	I:C0026348
modeling	I:C0026348
in	O
a	O
memory	O
clinic	I:C0442592
population	O
.	O

We	O
sought	O
to	O
define	O
a	O
cutoff	O
for	O
β-	O
amyloid	I:C0169424
1	I:C0169424
-	I:C0169424
42	I:C0169424
in	O
cerebrospinal	O
fluid	I:C0007806
(	O
cerebrospinal	O
fluid	I:C0007806
)	O
,	O
a	O
key	O
marker	B:C0005516
for	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
(	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
)	O
,	O
with	O
data	O
-	O
driven	O
Gaussian	O
mixture	I:C0026348
modeling	I:C0026348
in	O
a	O
memory	O
clinic	I:C0442592
population	O
.	O

We	O
sought	O
to	O
define	O
a	O
cutoff	O
for	O
β-	O
amyloid	I:C0169424
1	I:C0169424
-	I:C0169424
42	I:C0169424
in	O
cerebrospinal	O
fluid	I:C0007806
(	O
cerebrospinal	O
fluid	I:C0007806
)	O
,	O
a	O
key	O
marker	O
for	O
Alzheimer	B:C0002395
's	I:C0002395
disease	I:C0002395
(	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
)	O
,	O
with	O
data	O
-	O
driven	O
Gaussian	O
mixture	I:C0026348
modeling	I:C0026348
in	O
a	O
memory	O
clinic	I:C0442592
population	O
.	O

We	O
sought	O
to	O
define	O
a	O
cutoff	O
for	O
β-	O
amyloid	I:C0169424
1	I:C0169424
-	I:C0169424
42	I:C0169424
in	O
cerebrospinal	O
fluid	I:C0007806
(	O
cerebrospinal	O
fluid	I:C0007806
)	O
,	O
a	O
key	O
marker	O
for	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
(	O
Alzheimer	B:C0002395
's	I:C0002395
disease	I:C0002395
)	O
,	O
with	O
data	O
-	O
driven	O
Gaussian	O
mixture	I:C0026348
modeling	I:C0026348
in	O
a	O
memory	O
clinic	I:C0442592
population	O
.	O

We	O
sought	O
to	O
define	O
a	O
cutoff	O
for	O
β-	O
amyloid	I:C0169424
1	I:C0169424
-	I:C0169424
42	I:C0169424
in	O
cerebrospinal	O
fluid	I:C0007806
(	O
cerebrospinal	O
fluid	I:C0007806
)	O
,	O
a	O
key	O
marker	O
for	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
(	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
)	O
,	O
with	O
data	O
-	O
driven	O
Gaussian	B:C0026348
mixture	I:C0026348
modeling	I:C0026348
in	O
a	O
memory	O
clinic	I:C0442592
population	O
.	O

We	O
sought	O
to	O
define	O
a	O
cutoff	O
for	O
β-	O
amyloid	I:C0169424
1	I:C0169424
-	I:C0169424
42	I:C0169424
in	O
cerebrospinal	O
fluid	I:C0007806
(	O
cerebrospinal	O
fluid	I:C0007806
)	O
,	O
a	O
key	O
marker	O
for	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
(	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
)	O
,	O
with	O
data	O
-	O
driven	O
Gaussian	O
mixture	I:C0026348
modeling	I:C0026348
in	O
a	O
memory	B:C0442592
clinic	I:C0442592
population	O
.	O

We	O
sought	O
to	O
define	O
a	O
cutoff	O
for	O
β-	O
amyloid	I:C0169424
1	I:C0169424
-	I:C0169424
42	I:C0169424
in	O
cerebrospinal	O
fluid	I:C0007806
(	O
cerebrospinal	O
fluid	I:C0007806
)	O
,	O
a	O
key	O
marker	O
for	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
(	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
)	O
,	O
with	O
data	O
-	O
driven	O
Gaussian	O
mixture	I:C0026348
modeling	I:C0026348
in	O
a	O
memory	O
clinic	I:C0442592
population	B:C1257890
.	O

We	O
performed	O
a	O
combined	O
cross-sectional	B:C0010362
and	O
prospective	O
cohort	I:C1709709
study	I:C1709709
.	O

We	O
performed	O
a	O
combined	O
cross-sectional	O
and	O
prospective	B:C1709709
cohort	I:C1709709
study	I:C1709709
.	O

We	O
selected	O
2462	O
subjects	B:C2349001
with	O
subjective	O
cognitive	I:C0234985
decline	I:C0234985
,	O
mild	O
cognitive	I:C1270972
impairment	I:C1270972
,	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
-	O
type	O
dementia	O
,	O
and	O
dementia	O
other	O
than	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
from	O
the	O
Amsterdam	O
Dementia	O
Cohort	O
.	O

We	O
selected	O
2462	O
subjects	O
with	O
subjective	B:C0234985
cognitive	I:C0234985
decline	I:C0234985
,	O
mild	O
cognitive	I:C1270972
impairment	I:C1270972
,	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
-	O
type	O
dementia	O
,	O
and	O
dementia	O
other	O
than	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
from	O
the	O
Amsterdam	O
Dementia	O
Cohort	O
.	O

We	O
selected	O
2462	O
subjects	O
with	O
subjective	O
cognitive	I:C0234985
decline	I:C0234985
,	O
mild	B:C1270972
cognitive	I:C1270972
impairment	I:C1270972
,	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
-	O
type	O
dementia	O
,	O
and	O
dementia	O
other	O
than	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
from	O
the	O
Amsterdam	O
Dementia	O
Cohort	O
.	O

We	O
selected	O
2462	O
subjects	O
with	O
subjective	O
cognitive	I:C0234985
decline	I:C0234985
,	O
mild	O
cognitive	I:C1270972
impairment	I:C1270972
,	O
Alzheimer	B:C0002395
's	I:C0002395
disease	I:C0002395
-	O
type	O
dementia	O
,	O
and	O
dementia	O
other	O
than	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
from	O
the	O
Amsterdam	O
Dementia	O
Cohort	O
.	O

We	O
selected	O
2462	O
subjects	O
with	O
subjective	O
cognitive	I:C0234985
decline	I:C0234985
,	O
mild	O
cognitive	I:C1270972
impairment	I:C1270972
,	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
-	O
type	O
dementia	B:C0497327
,	O
and	O
dementia	O
other	O
than	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
from	O
the	O
Amsterdam	O
Dementia	O
Cohort	O
.	O

We	O
selected	O
2462	O
subjects	O
with	O
subjective	O
cognitive	I:C0234985
decline	I:C0234985
,	O
mild	O
cognitive	I:C1270972
impairment	I:C1270972
,	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
-	O
type	O
dementia	O
,	O
and	O
dementia	B:C0497327
other	O
than	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
from	O
the	O
Amsterdam	O
Dementia	O
Cohort	O
.	O

We	O
selected	O
2462	O
subjects	O
with	O
subjective	O
cognitive	I:C0234985
decline	I:C0234985
,	O
mild	O
cognitive	I:C1270972
impairment	I:C1270972
,	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
-	O
type	O
dementia	O
,	O
and	O
dementia	O
other	O
than	O
Alzheimer	B:C0002395
's	I:C0002395
disease	I:C0002395
from	O
the	O
Amsterdam	O
Dementia	O
Cohort	O
.	O

We	O
selected	O
2462	O
subjects	O
with	O
subjective	O
cognitive	I:C0234985
decline	I:C0234985
,	O
mild	O
cognitive	I:C1270972
impairment	I:C1270972
,	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
-	O
type	O
dementia	O
,	O
and	O
dementia	O
other	O
than	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
from	O
the	O
Amsterdam	O
Dementia	B:C0497327
Cohort	O
.	O

We	O
selected	O
2462	O
subjects	O
with	O
subjective	O
cognitive	I:C0234985
decline	I:C0234985
,	O
mild	O
cognitive	I:C1270972
impairment	I:C1270972
,	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
-	O
type	O
dementia	O
,	O
and	O
dementia	O
other	O
than	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
from	O
the	O
Amsterdam	O
Dementia	O
Cohort	B:C0599755
.	O

We	O
defined	O
cerebrospinal	B:C0007806
fluid	I:C0007806
β-	O
amyloid	I:C0169424
1	I:C0169424
-	I:C0169424
42	I:C0169424
cutoffs	O
by	O
data	O
-	O
driven	O
Gaussian	O
mixture	I:C0026348
modeling	I:C0026348
in	O
the	O
total	O
population	O
and	O
in	O
subgroups	O
based	O
on	O
clinical	O
diagnosis	I:C0332140
,	O
age	O
,	O
and	O
apolipoprotein	O
E	I:C1446118
(	I:C1446118
APOE	I:C1446118
)	I:C1446118
genotype	I:C1446118
.	O

We	O
defined	O
cerebrospinal	O
fluid	I:C0007806
β-	B:C0169424
amyloid	I:C0169424
1	I:C0169424
-	I:C0169424
42	I:C0169424
cutoffs	O
by	O
data	O
-	O
driven	O
Gaussian	O
mixture	I:C0026348
modeling	I:C0026348
in	O
the	O
total	O
population	O
and	O
in	O
subgroups	O
based	O
on	O
clinical	O
diagnosis	I:C0332140
,	O
age	O
,	O
and	O
apolipoprotein	O
E	I:C1446118
(	I:C1446118
APOE	I:C1446118
)	I:C1446118
genotype	I:C1446118
.	O

We	O
defined	O
cerebrospinal	O
fluid	I:C0007806
β-	O
amyloid	I:C0169424
1	I:C0169424
-	I:C0169424
42	I:C0169424
cutoffs	O
by	O
data	O
-	O
driven	O
Gaussian	B:C0026348
mixture	I:C0026348
modeling	I:C0026348
in	O
the	O
total	O
population	O
and	O
in	O
subgroups	O
based	O
on	O
clinical	O
diagnosis	I:C0332140
,	O
age	O
,	O
and	O
apolipoprotein	O
E	I:C1446118
(	I:C1446118
APOE	I:C1446118
)	I:C1446118
genotype	I:C1446118
.	O

We	O
defined	O
cerebrospinal	O
fluid	I:C0007806
β-	O
amyloid	I:C0169424
1	I:C0169424
-	I:C0169424
42	I:C0169424
cutoffs	O
by	O
data	O
-	O
driven	O
Gaussian	O
mixture	I:C0026348
modeling	I:C0026348
in	O
the	O
total	O
population	O
and	O
in	O
subgroups	B:C1515021
based	O
on	O
clinical	O
diagnosis	I:C0332140
,	O
age	O
,	O
and	O
apolipoprotein	O
E	I:C1446118
(	I:C1446118
APOE	I:C1446118
)	I:C1446118
genotype	I:C1446118
.	O

We	O
defined	O
cerebrospinal	O
fluid	I:C0007806
β-	O
amyloid	I:C0169424
1	I:C0169424
-	I:C0169424
42	I:C0169424
cutoffs	O
by	O
data	O
-	O
driven	O
Gaussian	O
mixture	I:C0026348
modeling	I:C0026348
in	O
the	O
total	O
population	O
and	O
in	O
subgroups	O
based	O
on	O
clinical	B:C0332140
diagnosis	I:C0332140
,	O
age	O
,	O
and	O
apolipoprotein	O
E	I:C1446118
(	I:C1446118
APOE	I:C1446118
)	I:C1446118
genotype	I:C1446118
.	O

We	O
defined	O
cerebrospinal	O
fluid	I:C0007806
β-	O
amyloid	I:C0169424
1	I:C0169424
-	I:C0169424
42	I:C0169424
cutoffs	O
by	O
data	O
-	O
driven	O
Gaussian	O
mixture	I:C0026348
modeling	I:C0026348
in	O
the	O
total	O
population	O
and	O
in	O
subgroups	O
based	O
on	O
clinical	O
diagnosis	I:C0332140
,	O
age	O
,	O
and	O
apolipoprotein	B:C1446118
E	I:C1446118
(	I:C1446118
APOE	I:C1446118
)	I:C1446118
genotype	I:C1446118
.	O

We	O
investigated	O
whether	O
abnormal	B:C0205161
β-	O
amyloid	I:C0169424
1	I:C0169424
-	I:C0169424
42	I:C0169424
as	O
defined	O
by	O
the	O
data	O
-	O
driven	O
cutoff	O
could	O
better	O
predict	O
progression	O
to	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
-	O
type	O
dementia	O
than	O
abnormal	O
β-	O
amyloid	I:C0169424
1	I:C0169424
-	I:C0169424
42	I:C0169424
defined	O
by	O
a	O
clinical	O
diagnosis	I:C0332140
-	O
based	O
cutoff	O
using	O
Cox	O
proportional	I:C0010235
hazards	I:C0010235
regression	I:C0010235
.	O

We	O
investigated	O
whether	O
abnormal	O
β-	B:C0169424
amyloid	I:C0169424
1	I:C0169424
-	I:C0169424
42	I:C0169424
as	O
defined	O
by	O
the	O
data	O
-	O
driven	O
cutoff	O
could	O
better	O
predict	O
progression	O
to	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
-	O
type	O
dementia	O
than	O
abnormal	O
β-	O
amyloid	I:C0169424
1	I:C0169424
-	I:C0169424
42	I:C0169424
defined	O
by	O
a	O
clinical	O
diagnosis	I:C0332140
-	O
based	O
cutoff	O
using	O
Cox	O
proportional	I:C0010235
hazards	I:C0010235
regression	I:C0010235
.	O

We	O
investigated	O
whether	O
abnormal	O
β-	O
amyloid	I:C0169424
1	I:C0169424
-	I:C0169424
42	I:C0169424
as	O
defined	O
by	O
the	O
data	O
-	O
driven	O
cutoff	O
could	O
better	O
predict	O
progression	O
to	O
Alzheimer	B:C0002395
's	I:C0002395
disease	I:C0002395
-	O
type	O
dementia	O
than	O
abnormal	O
β-	O
amyloid	I:C0169424
1	I:C0169424
-	I:C0169424
42	I:C0169424
defined	O
by	O
a	O
clinical	O
diagnosis	I:C0332140
-	O
based	O
cutoff	O
using	O
Cox	O
proportional	I:C0010235
hazards	I:C0010235
regression	I:C0010235
.	O

We	O
investigated	O
whether	O
abnormal	O
β-	O
amyloid	I:C0169424
1	I:C0169424
-	I:C0169424
42	I:C0169424
as	O
defined	O
by	O
the	O
data	O
-	O
driven	O
cutoff	O
could	O
better	O
predict	O
progression	O
to	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
-	O
type	O
dementia	B:C0497327
than	O
abnormal	O
β-	O
amyloid	I:C0169424
1	I:C0169424
-	I:C0169424
42	I:C0169424
defined	O
by	O
a	O
clinical	O
diagnosis	I:C0332140
-	O
based	O
cutoff	O
using	O
Cox	O
proportional	I:C0010235
hazards	I:C0010235
regression	I:C0010235
.	O

We	O
investigated	O
whether	O
abnormal	O
β-	O
amyloid	I:C0169424
1	I:C0169424
-	I:C0169424
42	I:C0169424
as	O
defined	O
by	O
the	O
data	O
-	O
driven	O
cutoff	O
could	O
better	O
predict	O
progression	O
to	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
-	O
type	O
dementia	O
than	O
abnormal	B:C0205161
β-	O
amyloid	I:C0169424
1	I:C0169424
-	I:C0169424
42	I:C0169424
defined	O
by	O
a	O
clinical	O
diagnosis	I:C0332140
-	O
based	O
cutoff	O
using	O
Cox	O
proportional	I:C0010235
hazards	I:C0010235
regression	I:C0010235
.	O

We	O
investigated	O
whether	O
abnormal	O
β-	O
amyloid	I:C0169424
1	I:C0169424
-	I:C0169424
42	I:C0169424
as	O
defined	O
by	O
the	O
data	O
-	O
driven	O
cutoff	O
could	O
better	O
predict	O
progression	O
to	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
-	O
type	O
dementia	O
than	O
abnormal	O
β-	B:C0169424
amyloid	I:C0169424
1	I:C0169424
-	I:C0169424
42	I:C0169424
defined	O
by	O
a	O
clinical	O
diagnosis	I:C0332140
-	O
based	O
cutoff	O
using	O
Cox	O
proportional	I:C0010235
hazards	I:C0010235
regression	I:C0010235
.	O

We	O
investigated	O
whether	O
abnormal	O
β-	O
amyloid	I:C0169424
1	I:C0169424
-	I:C0169424
42	I:C0169424
as	O
defined	O
by	O
the	O
data	O
-	O
driven	O
cutoff	O
could	O
better	O
predict	O
progression	O
to	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
-	O
type	O
dementia	O
than	O
abnormal	O
β-	O
amyloid	I:C0169424
1	I:C0169424
-	I:C0169424
42	I:C0169424
defined	O
by	O
a	O
clinical	B:C0332140
diagnosis	I:C0332140
-	O
based	O
cutoff	O
using	O
Cox	O
proportional	I:C0010235
hazards	I:C0010235
regression	I:C0010235
.	O

We	O
investigated	O
whether	O
abnormal	O
β-	O
amyloid	I:C0169424
1	I:C0169424
-	I:C0169424
42	I:C0169424
as	O
defined	O
by	O
the	O
data	O
-	O
driven	O
cutoff	O
could	O
better	O
predict	O
progression	O
to	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
-	O
type	O
dementia	O
than	O
abnormal	O
β-	O
amyloid	I:C0169424
1	I:C0169424
-	I:C0169424
42	I:C0169424
defined	O
by	O
a	O
clinical	O
diagnosis	I:C0332140
-	O
based	O
cutoff	O
using	O
Cox	B:C0010235
proportional	I:C0010235
hazards	I:C0010235
regression	I:C0010235
.	O

In	O
the	O
total	O
group	O
of	O
patients	O
,	O
we	O
found	O
a	O
cutoff	O
for	O
abnormal	B:C0205161
cerebrospinal	O
fluid	I:C0007806
β-	O
amyloid	I:C0169424
1	I:C0169424
-	I:C0169424
42	I:C0169424
of	O
680	O
pg/ml	O
(	O
95	O
%	O
CI	O
660-705	O
pg/ml	O
)	O
.	O

In	O
the	O
total	O
group	O
of	O
patients	O
,	O
we	O
found	O
a	O
cutoff	O
for	O
abnormal	O
cerebrospinal	B:C0007806
fluid	I:C0007806
β-	O
amyloid	I:C0169424
1	I:C0169424
-	I:C0169424
42	I:C0169424
of	O
680	O
pg/ml	O
(	O
95	O
%	O
CI	O
660-705	O
pg/ml	O
)	O
.	O

In	O
the	O
total	O
group	O
of	O
patients	O
,	O
we	O
found	O
a	O
cutoff	O
for	O
abnormal	O
cerebrospinal	O
fluid	I:C0007806
β-	B:C0169424
amyloid	I:C0169424
1	I:C0169424
-	I:C0169424
42	I:C0169424
of	O
680	O
pg/ml	O
(	O
95	O
%	O
CI	O
660-705	O
pg/ml	O
)	O
.	O

Similar	O
cutoffs	O
were	O
found	O
within	O
diagnostic	B:C0011900
and	O
APOE	O
genotype	I:C1446118
subgroups	O
.	O

Similar	O
cutoffs	O
were	O
found	O
within	O
diagnostic	O
and	O
APOE	B:C1446118
genotype	I:C1446118
subgroups	O
.	O

Similar	O
cutoffs	O
were	O
found	O
within	O
diagnostic	O
and	O
APOE	O
genotype	I:C1446118
subgroups	B:C1515021
.	O

The	O
cutoff	O
was	O
higher	O
in	O
elderly	B:C0001792
subjects	O
than	O
in	O
younger	O
subjects	O
.	O

The	O
cutoff	O
was	O
higher	O
in	O
elderly	O
subjects	B:C2349001
than	O
in	O
younger	O
subjects	O
.	O

The	O
cutoff	O
was	O
higher	O
in	O
elderly	O
subjects	O
than	O
in	O
younger	O
subjects	B:C2349001
.	O

The	O
data	O
-	O
driven	O
cutoff	O
was	O
higher	O
than	O
our	O
clinical	B:C0332140
diagnosis	I:C0332140
-	O
based	O
cutoff	O
and	O
had	O
a	O
better	O
predictive	O
accuracy	O
for	O
progression	O
to	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
-	O
type	O
dementia	O
in	O
nondemented	O
subjects	O
(	O
HR	O
7.6	O
versus	O
5.2	O
,	O
p	O
<	O
0.01	O
)	O
.	O

The	O
data	O
-	O
driven	O
cutoff	O
was	O
higher	O
than	O
our	O
clinical	O
diagnosis	I:C0332140
-	O
based	O
cutoff	O
and	O
had	O
a	O
better	O
predictive	O
accuracy	O
for	O
progression	O
to	O
Alzheimer	B:C0002395
's	I:C0002395
disease	I:C0002395
-	O
type	O
dementia	O
in	O
nondemented	O
subjects	O
(	O
HR	O
7.6	O
versus	O
5.2	O
,	O
p	O
<	O
0.01	O
)	O
.	O

The	O
data	O
-	O
driven	O
cutoff	O
was	O
higher	O
than	O
our	O
clinical	O
diagnosis	I:C0332140
-	O
based	O
cutoff	O
and	O
had	O
a	O
better	O
predictive	O
accuracy	O
for	O
progression	O
to	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
-	O
type	O
dementia	B:C0497327
in	O
nondemented	O
subjects	O
(	O
HR	O
7.6	O
versus	O
5.2	O
,	O
p	O
<	O
0.01	O
)	O
.	O

The	O
data	O
-	O
driven	O
cutoff	O
was	O
higher	O
than	O
our	O
clinical	O
diagnosis	I:C0332140
-	O
based	O
cutoff	O
and	O
had	O
a	O
better	O
predictive	O
accuracy	O
for	O
progression	O
to	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
-	O
type	O
dementia	O
in	O
nondemented	O
subjects	B:C2349001
(	O
HR	O
7.6	O
versus	O
5.2	O
,	O
p	O
<	O
0.01	O
)	O
.	O

Mixture	B:C0026348
modeling	I:C0026348
is	O
a	O
robust	O
method	O
to	O
determine	O
cutoffs	O
for	O
cerebrospinal	O
fluid	I:C0007806
β-	O
amyloid	I:C0169424
1	I:C0169424
-	I:C0169424
42	I:C0169424
.	O

Mixture	O
modeling	I:C0026348
is	O
a	O
robust	O
method	B:C0025663
to	O
determine	O
cutoffs	O
for	O
cerebrospinal	O
fluid	I:C0007806
β-	O
amyloid	I:C0169424
1	I:C0169424
-	I:C0169424
42	I:C0169424
.	O

Mixture	O
modeling	I:C0026348
is	O
a	O
robust	O
method	O
to	O
determine	O
cutoffs	O
for	O
cerebrospinal	B:C0007806
fluid	I:C0007806
β-	O
amyloid	I:C0169424
1	I:C0169424
-	I:C0169424
42	I:C0169424
.	O

Mixture	O
modeling	I:C0026348
is	O
a	O
robust	O
method	O
to	O
determine	O
cutoffs	O
for	O
cerebrospinal	O
fluid	I:C0007806
β-	B:C0169424
amyloid	I:C0169424
1	I:C0169424
-	I:C0169424
42	I:C0169424
.	O

It	O
might	O
better	O
capture	O
biological	O
changes	O
that	O
are	O
related	O
to	O
Alzheimer	B:C0002395
's	I:C0002395
disease	I:C0002395
than	O
cutoffs	O
based	O
on	O
clinical	O
diagnosis	I:C0332140
.	O

It	O
might	O
better	O
capture	O
biological	O
changes	O
that	O
are	O
related	O
to	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
than	O
cutoffs	O
based	O
on	O
clinical	B:C0332140
diagnosis	I:C0332140
.	O

